StockData
Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc. (NAUT) stock

NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 6/30
$2.43+0.07 (+2.97%)

Close on Nov 18, 2026Market cap $309.52MP/E –Yield –

Nautilus Biotechnology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Nautilus Biotechnology's price to book ratio was 2.3× on Nov 11, 2026, against 1.7× a year earlier. Over the last 5 years it ranged from 0.4× to 3.1×, with a median of 1.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.3×+0.9
2025Dec 31, 20251.5×+0.5
2024Dec 31, 20240.9×−0.4
2023Dec 29, 20231.3×+0.7
2022Dec 30, 20220.7×−1.0
2021Dec 31, 20211.7×–

More Nautilus Biotechnology figures

See a number that looks wrong?